Champions Oncolog (CSBR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 04/30
| 10-2000 | 07-2000 | 04-2000 | 01-2000 | 10-1999 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -169 | -9 | 50 | 87 | 30 |
| Depreciation Amortization | 24 | 12 | 50 | 36 | 20 |
| Accounts receivable | 108 | -72 | -113 | 0 | N/A |
| Accounts payable and accrued liabilities | -25 | 22 | 11 | 30 | N/A |
| Other Working Capital | 76 | -33 | -110 | 8 | -50 |
| Other Operating Activity | -33 | 99 | 102 | -124 | 10 |
| Operating Cash Flow | $-19 | $20 | $-10 | $38 | $10 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -27 | -15 | -10 | -6 | -1 |
| Purchase Of Investment | N/A | N/A | -1,065 | -375 | N/A |
| Sale Of Investment | N/A | N/A | 968 | 368 | N/A |
| Other Investing Activity | 0 | 0 | -3 | 0 | -209 |
| Investing Cash Flow | $-27 | $-15 | $-110 | $-13 | $-210 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -4 | -2 | -6 | -4 | N/A |
| Other Financing Activity | 0 | 0 | 0 | 0 | -2 |
| Financing Cash Flow | $-4 | $-2 | $-6 | $-4 | $-2 |
| Beginning Cash Position | 591 | 591 | 720 | 726 | 720 |
| End Cash Position | 542 | 594 | 590 | 747 | 520 |
| Net Cash Flow | $-50 | $3 | $-130 | $21 | $-200 |
| Free Cash Flow | |||||
| Operating Cash Flow | -19 | 20 | -10 | 38 | 10 |
| Capital Expenditure | -27 | -15 | -14 | -6 | N/A |
| Free Cash Flow | -46 | 5 | -24 | 31 | 10 |